Home › CRYOCONCEPTS, LP › CryoLab Medical
CryoLab Medical
CRYOCONCEPTS, LP · Model 200-1000 · UDI-DI 00850077006067
GEH
Prescription
1
510(k) clearances
3,274
Adverse events (57 deaths)
107
Recalls
112
Facilities
Description
The CryoLab® Medical device uses CryoConcepts’ design and technology to deliver a spray of either Nitrous Oxide or Carbon Dioxide gas respectively to treat topical cutaneous lesions. The intended use for the CryoLab®, for both gases, is the surgical destruction of target tissue by extreme cold temperatures. Specifically, example lesions the device is intended to treat, based upon the literature, include molluscum contagiosum, skin tags, actinic keratosis, lentigo, verruca plana, verruca vulgaris, verruca plantaris, genital lesions, and seborrheic keratosis.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-08-24 | Limitless Cryo Spa LLC | Lack of 510(k) clearance. |
| 2026-06-26 | Erbe USA Inc | A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the |
| 2026-02-12 | Erbe USA Inc | Probes may rupture/burst during activation |
| 2026-02-12 | Erbe USA Inc | Probes may rupture/burst during activation |
| 2026-02-12 | Erbe USA Inc | Probes may rupture/burst during activation |
| 2025-08-18 | Boston Scientific Corporation | Certain desiccant tube subassemblies were built with end caps that were not correctly tightened. |
| 2025-08-18 | Boston Scientific Corporation | Certain desiccant tube subassemblies were built with end caps that were not correctly tightened. |
| 2025-03-24 | Boston Scientific Corporation | Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings |
| 2025-03-24 | Boston Scientific Corporation | Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings |
| 2025-03-24 | Boston Scientific Corporation | Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.